Cisplatin in Combination With Either Gemcitabine or Irinotecan in Carcinomas of Unknown Primary Site: Results of a Randomized Phase II Study—Trial for the French Study Group on Carcinomas of Unknown ...
CENTENNIAL, Colo.--(BUSINESS WIRE)--Cell>Point announced today that it has received a letter from the U.S. Food and Drug Administration (FDA) indicating agreement on a Special Protocol Assessment (SPA ...
Technetium-99m, a critical nuclear imaging radioisotope, is in short supply and could cause delays or cancellations of over 40,000 medical imaging studies daily in the United States. The global ...
LONDON, Feb. 23, 2022 /PRNewswire/ -- Theragnostics announces that NephroScan, its radiodiagnostic imaging drug used as an aid for the evaluation of renal parenchymal disorders in adult and pediatric ...
Tackling supply shortages: As the supply chain for medical radioisotopes continues to struggle, researchers are developing new methods for producing technetium-99m, and exploring the potential of ...
The decay product of the medical isotope molybdenum-99 (Mo-99), technetium-99m (Tc-99m), and associated medical isotopes iodine-131 (I-131) and xenon-133 (Xe-133) are used worldwide for medical ...
ST. LOUIS, April 02, 2025 (GLOBE NEWSWIRE) -- Curium announced today that the U.S. Food and Drug Administration approved its generic version of the Kit for the Preparation of Technetium Tc 99m ...
DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB), today reported data at the American Association of Cancer Research (AACR) Annual Meeting 2015 demonstrating that the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback